ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,645Medicare Part D Prescriptions Filled, Including Refills

Rank: 1356 out of 6645

$1.02M Total Retail Price of All Prescriptions

Rank: 308 out of 6645

726 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 726 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 6,741 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$133 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 990 870 1 4
METFORMIN HCL ER 586 514 2 89
JANUVIA 467 426 3 38
GLIMEPIRIDE 449 398 4 47
SIMVASTATIN 362 320 5 1
ACTOS 359 332 6 71
LISINOPRIL 265 220 7 3
METFORMIN HCL 260 244 8 7
PIOGLITAZONE HCL 231 210 R 10 9 184
GLIPIZIDE ER 226 207 10 239
ONGLYZA 183 162 11 168
FENOFIBRATE 145 120 12 74
GLIPIZIDE XL 141 130 13 315
LANTUS 136 123 14 50
WELCHOL 115 114 15 199
ALENDRONATE SODIUM 110 98 16 14
AMLODIPINE BESYLATE 100 92 17 2
INSULIN SYRINGE 97 86 18 61
FUROSEMIDE 94 77 19 11
LIOTHYRONINE SODIUM 76 44 20 338
HYDROCODONE-ACETAMINOPHEN 73 66 S3 21 5
LOVASTATIN 68 62 22 15
ATORVASTATIN CALCIUM 67 62 23 10
HUMALOG 65 56 24 137
VICTOZA 3-PAK 65 45 24 365
PEN NEEDLE 60 47 26 159
CRESTOR 60 46 26 34
LOSARTAN POTASSIUM 59 49 28 12
SYNTHROID 54 36 29 79
ATENOLOL 54 47 29 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.